Metabolic and cardiovascular benefits of GLP-1 agonists, besides the hypoglycemic effect (Review)

Patients with type 2 diabetes exhibit higher cardiovascular risk than normal individuals. Optimal blood glucose levels are rarely achieved in diabetic patients. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as a new antidiabetic drug class with multiple metabolic effects. Some t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Exp Ther Med
Main Authors: Iorga, Roua Anamaria, Bacalbasa, Nicolae, Carsote, Mara, Bratu, Ovidiu Gabriel, Stanescu, Ana Maria Alexandra, Bungau, Simona, Pantis, Carmen, Diaconu, Camelia Cristina
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7401476/
https://ncbi.nlm.nih.gov/pubmed/32765722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.8714
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados